Scott Gottlieb, MD, former FDA Commissioner

Download Now!
*Please note that this on-demand webinar will be available until Wednesday, February 3, 2021. 

Distribution and management of COVID-19 vaccines is one of the most significant global health initiatives in history. Governments, health care organizations, and private sector companies need the ability to operate with the utmost visibility and efficiency, as well as the ability to protect and communicate with their people.  At the same time, there are many unknowns and uncertainty as plans unfold.  The public is eager to understand when they will receive the much-anticipated vaccines, governments want to ensure information is clearly disseminated and employers are interested in solidifying plans for the future of work.  

Join Everbridge as we speak with Dr. Scott Gottlieb about:

  • Vaccine distribution, efficacy, concerns, and rumors
  • Latest on distribution logistics
  • Best practices for vaccine distribution management and communication
  • The obligation of government and employers
  • Role Everbridge is playing in this effort
  • What’s next?

About the speaker

Dr-Scott-Gottlieb-170x170px_4.23.jpgScott Gottlieb, MD, is a physician and served as the 23rd Commissioner of the U.S. Food and Drug Administration. Dr. Gottlieb’s work focuses on advancing public health through developing and implementing innovative approaches to improving medical outcomes, reshaping healthcare delivery, and expanding consumer choice and safety. Dr. Gottlieb is an aggressive advocate for advancing the health of patients, promoting healthcare access, and driving innovation. Previously, Dr. Gottlieb served as the FDA’s Deputy Commissioner for Medical and Scientific Affairs and before that, as a Senior Adviser to the Administrator of the Centers for Medicare and Medicaid Services, where he helped advance policies to improve healthcare quality and promote the effective use of new medical technologies. A healthcare futurist, he has worked as a venture capitalist and founder and board member to companies that have developed new medicines and advance the delivery of healthcare. Fortune Magazine recognized him as one of the “World’s 50 Greatest Leaders” in 2018 and again in 2019.

Watch the Webinar